Skip to main content
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1993 Sep;84(9):989–995. doi: 10.1111/j.1349-7006.1993.tb00190.x

Aberrant α1→2Fucosyltransferases Found in Human Colorectal Carcinoma Involved in the Accumulation of Leb and Y Antigens in Colorectal Tumors

Shin Yazawa 1,, Jun‐ichi Nakamura 2, Takayuki Asao 2, Yukio Nagamachi 2, Morihisa Sagi 3, Khushi L Malta 4, Tetsuya T Achikawa 5, Masaru Akamatsu 5
PMCID: PMC5919283  PMID: 8407568

Abstract

Evidence indicates that the presence of aberrant α1→2fucosylation pathways is responsible for the accumulation of large quantities of Leb and Y antigens in human colorectal carcinoma. Significantly higher activities of α1→2 as well as α1→3 and α1→4fucosyltransferases were found in most of the tissues from carcinoma than in the adjacent normal tissues and in healthy subjects. α1→2Fucosyl‐transferases associated with the synthesis of Leb (Fucal→2Galβ1→3[Fucc1→4]GlcNAcβ) and Y (Fucα1→2Ga1β→4[Fucα1→3]GlcNAcβ) structures from Le (GaIβ1→3[Fucal→4]GlcNAcβ) and X (Galβ1→4[Fucα 1→3]GlcNAcβ) ones, respectively, were demonstrated in colorectal carcinomas and in colorectal carcinoma cell lines (COLO201, LS174T and SW1116). The activation of α1→2fucosyltransferase with such new substrate specificities in colorectal carcinoma might result in the preferential synthesis of Leb and Y structures from Le and X rather than from H type 1 and H type 2 structures.

Keywords: α1→2Fucosyltransferase, Colorectal cancer, Leb and Y antigen, Tumor‐associated antigen

Full Text

The Full Text of this article is available as a PDF (383.2 KB).

REFERENCES

  • 1.Hakomori , S, Aberrant glycosylation in cancer cell membranes as focused on glycolipid: overview and perspectives . Cancer Res. , 45 , 2405 – 2414 ( 1985. ). [PubMed] [Google Scholar]
  • 2.Hakomori , S.Sphingolipids with Leb activity, and the co‐presence of Lea, Leb‐glycolipids in human tumor tissue . Biochim. Biophys. Acta , 202 , 225 – 228 ( 1970. ). [DOI] [PubMed] [Google Scholar]
  • 3.Shoentag , R. , Primus , F. J. and Kuhns , W.ABH and Lewis blood group expression in colorectal carcinoma . Cancer Res. , 47 , 1655 – 1700 ( 1983. ). [PubMed] [Google Scholar]
  • 4.Abe , K. , Hakomori , S. and Oshiba , S.Differential expression of difucosyl type 2 chain (LeY) defined by monoclonal antibody AH6 in different location of colonic epithelia, various histological types of colonic polyps, and adeno‐carcinomas . Cancer Res. , 46 , 2639 – 2644 ( 1986. ). [PubMed] [Google Scholar]
  • 5.Pour , P. M. , Tempero , M. M. , Takasaki , H. , Uchida , E. , Takiyama , Y. , Burnett , D. A. and Seplewski , Z.Expression of blood group‐related antigens ABH, Lewis A, Lewis B, Lewis X, Lewis Y, and CA19‐9 in pancreatic cancer cells in comparison with the patient's blood group type . Cancer Res. , 48 , 5422 – 5426 ( 1988. ). [PubMed] [Google Scholar]
  • 6.Sakamoto , J. , Furukawa , K. , Cordon‐Cardo , C. , Yin , B. W. T. , Rettig , W. J. , Oettgen , H. F , Old , L. J. and Lloyd , K. U.Expression of Lewisa, Lewisb, X and Y blood group antigens in human colorectal tumors and normal tissue and in human tumor‐derived cell lines . Cancer Res. , 46 , 1553 – 1561 ( 1986. ). [PubMed] [Google Scholar]
  • 7.Kim , Y. S. , Yuan , M. , Itzkowitz , S. H. , Sun , Q. , Kaizu , T. , Palekar , A. , Trump , B. F. and Hakomori , S.Expression of Ley and extended Ley blood group‐related antigens in human malignant, premalignant, and non‐malignant colonic tissues . Cancer Res. , 46 , 5985 – 5992 ( 1986. ). [PubMed] [Google Scholar]
  • 8.Langkilde , N. C. , Wolf , H. and Ørntoft , T. F.Lewis antigen expression in benign and malignant tissues from RBC Le(a‐b‐) cancer patients . Br. J. Haematol. , 79 , 493 – 499 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 9.Ørntoft , T. F. , Greenwell , P. , Clausen , H. and Watkins , W. M.Regulaion of the oncodevelopmental expression of type 1 chain ABH and Lewisb blood group antigens in human colon by α‐2‐L‐fucosylation . Gut , 32 , 287 – 293 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Salmon , C. , Cartron , J.‐P. and Rouger , P. “ The Human Blood Groups ,” pp. 54 – 80 ( 1984. ). Masson Publishing; , New York . [Google Scholar]
  • 11.Weiser , M. M. , Klohs , W. D. , Podolsky , D. K. and Wilson , J. R. “ The Glycoconjugates ,” Vol. IV , ed. Horowitz M. I. , pp. 301 – 333 ( 1982. ). Academic Press; , New York . [Google Scholar]
  • 12.Yazawa , S. , Madiyalakan , R. , Izawa , H. , Asao , T. , Furukawa , K. and Matta , K. L.Cancer‐associated elevation of α(l→3)‐L‐fucosyltransferase activity in human serum . Cancer , 62 , 516 – 520 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 13.Yazawa , S. , Asao , T. , Izawa , H. , Miyamoto , Y. and Matta , K. L.The presence of CA 19–9 in serum and saliva from Lewis blood‐group negative cancer patients . Jpn. J. Cancer Res. , 79 , 538 – 543 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Yazawa , S. , Asao , T. , Nagamachi , Y. and Matta , K. L.Elevated activities of serum α(1→3)‐L‐fucosyltransferase in human cancer . J. Tumor Marker Oncol. , 4 , 355 – 362 ( 1989. ). [Google Scholar]
  • 15.Uemura , M. , Sakaguchi , R. , Uejima , T. , Nozawa , S. and Narimatsu , H.Mouse monoclonal antibodies which recognize a human (β1–4)galactosyltransferase associated with tumor in body fluids . Cancer Res. , 52 , 6153 – 6157 ( 1992. ). [PubMed] [Google Scholar]
  • 16.Blaszczyk‐Thurin , M. , Sarnesto , A. , Thurin , J. , Hindsgaul , O. and Koplowski , H.Biosynthetic pathways for the Leb and Y glycolipids in the gastric carcinoma cell line KATO III as analyzed by a novel assay . Biochem. Biophys. Res. Commun. , 151 , 100 – 108 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 17.Yazawa , S. , Madiyalakan , R. , Jain , R. K. , Shimoda , N. and Matta , K. L.Use of benzyl 2‐acetamido‐2‐deoxy‐3‐O‐ (2‐O‐methyl‐β‐d‐galactosyl)‐β‐d‐glucopyranoside [2′‐O‐ methyllacto‐N‐biose IβBn] as a specific acceptor for GDP‐fucose: N‐ acetylglucosaminide α(1→4) ‐l‐ fucosyltrans‐ferase . Anal. Biochem. , 187 , 374 – 378 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 18.Yazawa , S. , Akamatsu , S. , Tachikawa , T. , Naitoh , H. , Nakamura , J. , Asao , T. , Nagamachi , Y. , Nakajima , T. , Shin , S. and Chia , D.Development and characterization of a novel anti‐fucosylated antigen monoclonal antibody YB‐2 and its usefulness in the immunohistochemical diagnosis of colorectal cancer . Jpn. J. Cancer Res. , 84 , 641 – 648 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Yazawa , S. , Takeya , A. , Hosomi , A. , Nakajima , T. , Shimoda , N. , Ohi , H. , Tachikawa , T. , Piscorz , C. F. , Jain , R. K. and Matta , K. L.Use of synthetic H disaccharides as acceptors for detecting activities of UDP‐GalNAc: Fucα1→2Galβ‐R α1→3‐N‐acetylgalacto‐saminyltransferase in plasma samples from blood group A subgroups . Clin. Chem. , 38 , 2392 – 2395 ( 1992. ). [PubMed] [Google Scholar]
  • 20.Dakour , J. , Zopf , D. and Lundblad , A.Assay of α1,3N‐ acetyl‐d‐galactosaminyl transferase by affinity chromatography . Anal. Biochem. , 204 , 210 – 214 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 21.Oriol , R. , Danilovs , J. and Hawkins , B. R.A new genetic model proposing that the Se gene is a structural gene closely linked to the H gene . Am. J. Human Genet. , 33 , 421 – 431 ( 1981. ). [PMC free article] [PubMed] [Google Scholar]
  • 22.Oriol , R. , Le Pendu , J. and Mollicone , R.Genetics of ABO, H, Lewis, X and related antigens . Vox Sang. , 51 , 161 – 171 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 23.Yazawa , S. and Furukawa , K.Immunochemical properties of human plasma α1→2fucosyltransferase specified by blood group H‐gene . J. Immunogenet. , 10 , 349 – 360 ( 1983. ). [DOI] [PubMed] [Google Scholar]
  • 24.Sarnesto , A. , Köhlin , R. , Thurin , J. and Blaszczyk‐Thurin , M.Purification of H. gene‐encoded β‐galactoside α1→2fucosyltransferase from human serum . J. Biol. Chem. , 265 , 15067 – 15075 ( 1990. ). [PubMed] [Google Scholar]
  • 25.Sarnesto , A. , Köhlin , T. , Hindsgaul , O. , Thurin , J. and Blaszczyk‐Thurin , M.Purification of the secretor‐type β‐galactoside α1→2fucosyltransferase from human serum . J. Biol. Chem. , 267 , 2737 – 2744 ( 1992. ). [PubMed] [Google Scholar]
  • 26.Liepkans , V. A. and Larson , G.Biosynthesis of Lewis fucolipid antigens in human colorectal carcinoma cells. Partial characterization of LcOse4Cer and H‐1 fucolipid fucosyl transferase acceptor activities . Eur. J. Biochem. , 168 , 209 – 217 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 27.Yuan , M. , Itzkowitz , S. H. , Palekar , A. , Shamsuddin , A. M. , Phelps , P. C. , Trump , B. F. and Kim , Y. S.Distribution of blood group antigens A, B, H, Lewis a, and Lewis b in human normal, fetal, and malignant colonic tissue . Cancer Res. , 45 , 4499 – 4511 ( 1985. ). [PubMed] [Google Scholar]
  • 28.Chester , M. A. , Yates , A. D. and Watkins , W. M.Phenyl β‐d‐galactoside as an acceptor for the blood‐group H gene‐associated guanosine diphosphate l‐fucose:β‐d‐galactosyl α‐2‐l‐fucosyltransferase . Eur. J. Biochem. , 69 , 583 – 592 ( 1976. ). [Google Scholar]
  • 29.Larsen , R. D. , Ernst , L. K. , Nair , R. P. and Lowe , J. B.Molecular cloning, sequence, and expression of a human GDP‐l‐fucose:β‐d‐galactoside 2‐α‐l‐fucosyltransferase cDNA that can form the H blood group antigen . Proc, Natl. Acad. Sci. USA , 87 , 6674 – 6678 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Lowe , J. B. , Kukowska‐Latallo , J. F. , Nair , R. P. , Larsen , R. D. , Marks , R. M. , Macher , B. A. , Kelly , R. J. and Ernst , L. K.Molecular cloning of a human fucosyl‐transferase gene that determines expression of the Lewis x and VIM‐2 epitopes but not ELAM‐1‐dependent cell adhesion . J. Biol. Chem. , 266 , 17467 – 17477 ( 1991. ). [PubMed] [Google Scholar]
  • 31.Kumar , R. , Potvin , B. , Muller , W. A. and Stanley , P.Cloning of a human α(1, 3)‐fucosyltransferase gene that encodes ELFT but does not confer ELAM‐1 recognition on Chinese hamster ovary cell transfectants . J. Biol. Chem. , 266 , 21777 – 21783 ( 1991. ). [PubMed] [Google Scholar]
  • 32.Weston , R. , Nair , R. P. , Larsen , R. D. and Lowe , J. B.Isolation of a novel human α(1, 3) fucosyltransferase gene and molecular comparison to the human blood group a (1,3/1,4) fucosyltransferase gene . J. BioL Chem. , 267 , 4152 – 4160 ( 1992. ). [PubMed] [Google Scholar]
  • 33.Weston , B. W. , Smith , P. L. , Kelly , R. J. and Lowe , J. B.Molecular cloning of a fourth member of a human α(1,3)fucosyltransferase gene family . J. BioL Chem. , 267 , 24575 – 24584 ( 1992. ). [PubMed] [Google Scholar]
  • 34.Koszdin , K. L. and Bowen , B. R.The cloning and expression of a human α‐1,3 fucosyltransferase capable of forming the E‐selection ligand . Biochem. Biophys. Res. Commun. , 187 , 152 – 157 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 35.Nishihara , S. , Nakazato , M. , Kudo , T. , Kimura , H. and Ando , T. and Narimatsu , H.Human α‐1,3fucosyltransferase (FucT‐VI) gene is located at only 13Kb 3′ to the Lewis type fucosyltransferase (FucT‐III) gene on chromosome 19 . Biochem. Biophys. Res. Commun. , 190 , 42 – 46 ( 1993. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES